In a landmark preclinical study that promises to redefine the landscape of regenerative medicine, investigators at Weill Cornell Medicine have…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The biopharmaceutical industry, in its relentless pursuit of innovation and efficiency, faces a silent but profound challenge: the erosion of…
Read More
Voro Therapeutics and Alloy Therapeutics Forge Strategic Partnership to Revolutionize Tumour-Selective T-Cell Engager Therapies
Voro Therapeutics and Alloy Therapeutics have announced a significant strategic research partnership aimed at developing a new generation of masked…
Read More
University of Michigan Scientists Uncover Hidden Pathway Linking Peach Fuzz to Chronic Itch, Paving Way for Novel Therapies.
A groundbreaking discovery by researchers at the University of Michigan has illuminated a previously unknown biological mechanism underlying the sensation…
Read More
Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP
Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read More
EHA26: J&J’s multiple myeloma therapies impress with new data – Pharmaceutical Technology
The European Hematology Association (EHA) 2026 conference, held from June 11th to 14th in Stockholm, Sweden, served as a pivotal…
Read More
Simcere Pharmaceutical Group Partners with Stanford Medicine to Pioneer Novel Therapies for Idiopathic Pulmonary Fibrosis
Simcere Pharmaceutical Group has forged a significant research collaboration with Stanford Medicine, aiming to unlock novel therapeutic avenues for idiopathic…
Read More
FDA Approves a Wave of Oncology Innovations: New Therapies, Diagnostics, and Imaging Agents Usher in a New Era of Cancer Care
The US Food and Drug Administration (FDA) has recently authorized a series of significant advancements in oncology, encompassing novel therapeutic…
Read More
Lilly’s $7bn Acquisition of Kelonia Bears Fruit as In Vivo Cell Therapies Show Significant Promise at ASCO 2026
The American Society for Clinical Oncology (ASCO) meeting in 2026, a cornerstone event for oncological advancements, has concluded, leaving behind…
Read More
ASCO 2026: Lung Cancer Landscape Ignites with Promising Bispecifics, Targeted Therapies, and Extended Survival Data
The annual American Society of Clinical Oncology (ASCO) congress, a cornerstone event for the global oncology community, convened in Chicago,…
Read More
